Login / Signup

A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer.

Tetsuo ShimizuYoshiko NakagawaYasuo AsaiIchirou TsujinoNoriaki TakahashiYasuhiro Gon
Published in: The Journal of international medical research (2019)
Keyphrases
  • phase ii study
  • locally advanced
  • open label
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • metastatic colorectal cancer
  • placebo controlled
  • newly diagnosed
  • study protocol
  • double blind